Steven Cohen Halozyme Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $12.7 Million - $15.3 Million	-347,400 Reduced 91.53%	32,160 $1.23 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $116,971 - $149,652	-3,863 Reduced 1.01%	379,560 $13.7 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $8.59 Million - $14.6 Million	261,423 Added 214.28%	383,423 $14.6 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $7.28 Million - $10.8 Million	-181,839 Reduced 59.85%	122,000 $6.94 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $11.7 Million - $15.7 Million	303,839 New	303,839 $12 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $9.69 Million - $12.5 Million	-259,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $1.52 Million - $1.95 Million	47,400 Added 22.36%	259,400 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $6.75 Million - $8.64 Million	212,000 New	212,000 $8.53 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $1.64 Million - $2.14 Million	-41,500 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $1.47 Million - $2.48 Million	-56,792 Reduced 57.78%	41,500 $1.77 Million
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $548,854 - $631,800	21,323 Added 27.7%	98,292 $2.58 Million
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $1.73 Million - $2.85 Million	-106,246 Reduced 57.99%	76,969 $2.06 Million
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $2.55 Million - $4 Million	183,215 New	183,215 $3.3 Million
Q3 2019 Nov 15, 2019	SELL	$15.2 - $17.69 $18.1 Million - $21 Million	-1,187,660 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $17.5 Million - $20.5 Million	1,187,660 New	1,187,660 $20.4 Million

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$930 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$681 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$350 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$215 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$180 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account